Merck Higher Despite Trump Bashing
Merck & Co., Inc. (NYSE:MRK) shares are trading higher by 38 cents at $62.76 in Monday's session.
The stock is up despite negative comments about drug pricing from President Donald Trump, after Merck's CEO resigned from Trump's manufacturing council.
CEO Ken Frazier was disappointed by the commander-in-chief's reaction to the racial violence that took place over the weekend in Charlottesville, Virginia.
After a higher open, in sympathy with the broad market, Merck's stock had a brief decline to $62.61 before coming back to make a new high for the session at $63.00. That high coincides with Friday's high of $62.96 and is just shy of its August 7 high ($63.09).
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.